PRAGUE – Vaccination of children against pneumococcal diseases would save millions of lives all over the world. This was announced by the Pneumococcal Awareness Council of Experts (PACE) at today’s seminar in Prague. Pneumococcal disease causes pneumonia, encephalitis or barotitis. 400 cases of pneumonia are confirmed each year in the Czech Republic, and 14% of the infected children below five years of age die.
Czech specialists engaged the international Pneumococcal Awareness Council of Experts (PACE) and tried to negotiate with the Ministry of Health for implementation of routine pneumococcal vaccination. Vulnerable groups are mainly small children under two years of age and elders. Serious pneumococcal diseases result in about 430 patients per year, and 14 per cent of infected children die.
Did you know that Czech children can receive vaccination against the treacherous pneumococcal infection from two months of age? A three year-old boy has recently died from it in our country. Pneumococcus often causes serious infections in various parts of the human body. They can be divided into serious invasive disease and non-invasive infections of the upper breathing apparatus (barotitis, nasal cavity infl ammations).
Pneumococcal disease is little known, but deadly to more young children worldwide, than AIDS, malaria and measles.
Orin Levine from the Bloomberg School of Public Health says the bacterial infection is a neglected and preventable child killer.
A vaccine that fights pneumonia and other diseases could save the lives of thousands of children each year in Latin America, but high costs have kept it from those who need it, a researcher told a congress of health professionals Thursday.
NEW CANAAN, CT, January 30, 2006—The Board of Trustees of the Albert B. Sabin Vaccine Institute (Sabin) announced personnel changes made to strengthen the Institute’s efforts in the area of cancer vaccines. At a January 12 meeting in New York, the Board elected Axel Hoos, MD, PhD, as a trustee and approved the appointment of Robert Allen, MD, as vice president for cancer programs.
Achieving success in the global fight against the "big three" diseases-HIV/AIDS, tuberculosis and malaria, which together account for 5.6 million deaths a year-may well require a concurrent attack on the world's most neglected tropical diseases, says a team of researchers in the international open access journal PLoS Medicine.
WASHINGTON, D.C., Sept. 7, 2005 – The Albert B. Sabin Vaccine Institute (Sabin), a leader in promoting the development and use of safe and effective vaccines to prevent disease, announced receipt of a grant of $150,000 from the Bill & Melinda Gates Foundation for the sponsorship of a vaccine policy colloquium to be held at Cold Spring Harbor, Long Island, New York, October 19-21, 2005.
NEW CANAAN, CT—Thirty-five leading cancer vaccine researchers met to consider medical progress in treating cancer with vaccines during a three-day meeting convened by New Canaan’s Sabin Vaccine Institute (Sabin) held this past June.